Attitudes and Perceptions of Portuguese Psychiatrists and Psychologists on the Clinical Use of Ketamine
Acta Médica Portuguesa · 2025
DOI: 10.20344/amp.22815 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Médica Portuguesa, 2025. Verfasst von Pedro Mota und 6 weiteren Autor:innen. Beteiligte Einrichtung: Casa de Saúde de Santa Catarina. Porto. Portugal; Life and Health Sciences Research Institute (ICVS). Universidade do Minho. Braga. Portugal. Hauptthemen laut MEDLINE: Ketamine, Attitude of Health Personnel, Psychiatry, Psychology. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Ketamine has garnered attention for its rapid efficacy in alleviating depressive symptoms in treatment-resistant depression, offering a novel mechanism as a non-monoaminergic agent. Despite its potential, limited research has explored mental health professionals’ perspectives on its use. This study assesses the attitudes, knowledge, and concerns of Portuguese psychiatrists and psychologists regarding the clinical application of ketamine in treatment-resistant depression.
Methods
A cross-sectional survey study was conducted from June 2022 to January 2024 among Portuguese psychiatrists and psychologists. The anonymous online questionnaire assessed perceptions of ketamine’s therapeutic utility, risks, and knowledge sources. Statistical analyses examined subgroup differences by age, sex, profession, and prior psychedelic use.
Results
Among 156 participants (mean age = 37.2; 68.6% female), 53.8% were psychologists, and 46.2% were psychiatrists or trainees in Psychiatry. Only 35.9% reported substantial knowledge of ketamine’s therapeutic potential, while 59% were open to integrating it clinically. The majority expressed interest in training, though 73% raised concerns about inadequate professional training. Significant differences emerged, with psychiatrists reporting higher knowledge levels and openness to ketamine compared to psychologists, while younger professionals showed greater interest in training and usage.
Conclusion
There was a favorable attitude toward ketamine use among Portuguese psychiatrists and psychologists, yet substantial educational gaps remain. Customized training addressing age, sex, and professional background is essential for safe and effective clinical integration of ketamine in treatment-resistant depression. Further studies should focus on longitudinal outcomes of ketamine treatment under standardized protocols to ensure efficacy and safety in clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Casa de Saúde de Santa Catarina. Porto. Portugal; Life and Health Sciences Research Institute (ICVS). Universidade do Minho. Braga. Portugal.
- Centro Interdisciplinar de Estudo da Performance Humana. Faculdade de Motricidade Humana. Universidade de Lisboa. Lisbon. Portugal.
- Hospital de Magalhães Lemos. Unidade Local de Saúde de Santo António. Porto. Portugal.
- Center for Psychedelic and Consciousness Research. Johns Hopkins Medicine. Baltimore. Maryland. United States of America.
- Center for Excellence in Psilocybin Research and Treatment. Baltimore. Maryland. United States of America.
Zitieren
APA
Mota, P., Encantado, J., C Carvalho, L., Cunha, C., Garcia-Romeu, A., W Johnson, M., & J Teixeira, P. (2025). Attitudes and Perceptions of Portuguese Psychiatrists and Psychologists on the Clinical Use of Ketamine. Acta Médica Portuguesa. https://doi.org/10.20344/amp.22815
Vancouver
Mota P, Encantado J, C Carvalho L, Cunha C, Garcia-Romeu A, W Johnson M, et al. Attitudes and Perceptions of Portuguese Psychiatrists and Psychologists on the Clinical Use of Ketamine. Acta Médica Portuguesa. 2025. doi:10.20344/amp.22815
BibTeX
@article{Mota2025,
author = {Mota, Pedro and Encantado, Jorge and C Carvalho, Laura and Cunha, Catarina and Garcia-Romeu, Albert and W Johnson, Matthew and J Teixeira, Pedro},
title = {Attitudes and Perceptions of Portuguese Psychiatrists and Psychologists on the Clinical Use of Ketamine},
journal = {Acta Médica Portuguesa},
year = {2025},
doi = {10.20344/amp.22815}
}
EUVIMED